Staphylococcus aureus isolates with reduced susceptibility to glycopeptides belong to accessory gene regulator group I or II

被引：29

作者：

Verdier, I ^{[1
]}

Reverdy, ME ^{[1
]}

Etienne, J ^{[1
]}

Lina, G ^{[1
]}

Bes, M ^{[1
]}

Vandenesch, F ^{[1
]}

机构：

[1] Fac Med Laennec, Natl Reference Lab Staphylococci, INSERM E0230, IFR62, F-69372 Lyon 08, France

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2004年 / 48卷 / 03期

关键词：

D O I：

10.1128/AAC.48.3.1024-1027.2004

中图分类号：

Q93 [微生物学];

学科分类号：

071005 [微生物学]; 100705 [微生物与生化药学];

摘要：

We used multiplex PCR to determine the agr group membership of 18 European glycopeptide heterointermediate and intermediate-resistant Staphylococcus aureus strains. Of the 15 agr group I strains, 13 were resistant and 2 were susceptible to methicillin. The remaining three strains, like the United States and Japanese control strains, belonged to agr group II.

引用

页码：1024 / 1027

页数：4

共 24 条

[1]

Presence of Staphylococcus aureus with reduced susceptibility to vancomycin in Germany [J].

Bierbaum, G ;

Fuchs, K ;

Lenz, W ;

Szekat, C ;

Sahl, HG .

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1999, 18 (10) :691-696

[2]

Clinical isolate of vancomycin-heterointermediate Staphylococcus aureus susceptible to methicillin and in vitro selection of a vancomycin-resistant derivative [J].

Bobin-Dubreux, S ;

Reverdy, ME ;

Nervi, C ;

Rougier, M ;

Bolmström, A ;

Vandenesch, F ;

Etienne, J .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (01) :349-352

[3]

*CDCP, 1997, MMWR-MORBID MORTAL W, V46, P765

[4]

Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V48, P1165

[5]

Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene [J].

Chang, S ;

Sievert, DM ;

Hageman, JC ;

Boulton, ML ;

Tenover, FC ;

Downes, FP ;

Shah, S ;

Rudrik, JT ;

Pupp, GR ;

Brown, WJ ;

Cardo, D ;

Fridkin, SK .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (14) :1342-1347

[6]

Contribution of a thickened cell wall and its glutamine nonamidated component to the vancomycin resistance expressed by Staphylococcus aureus Mu50 [J].

Cui, LZ ;

Murakami, H ;

Kuwahara-Arai, K ;

Hanaki, H ;

Hiramatsu, K .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (09) :2276-2285

[7]

Emergence of vancomycin-intermediate Staphylococcus aureus in a Belgian hospital:: microbiological and clinical features [J].

Denis, O ;

Nonhoff, C ;

Byl, B ;

Knoop, C ;

Bobin-Dubreux, S ;

Struelens, MJ .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 50 (03) :383-391

[8]

Transcription profiling-based identification of Staphylococcus aureus genes regulated by the agr and/or sarA loci [J].

Dunman, PM ;

Murphy, E ;

Haney, S ;

Palacios, D ;

Tucker-Kellogg, G ;

Wu, S ;

Brown, EL ;

Zagursky, RJ ;

Shlaes, D ;

Projan, SJ .

JOURNAL OF BACTERIOLOGY, 2001, 183 (24) :7341-7353

[9]

RAPID METHOD FOR EPIDEMIOLOGIC EVALUATION OF GRAM-POSITIVE COCCI BY FIELD INVERSION GEL-ELECTROPHORESIS [J].

GOERING, RV ;

WINTERS, MA .

JOURNAL OF CLINICAL MICROBIOLOGY, 1992, 30 (03) :577-580

[10]

Activated cell-wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus clinical strains Mu3 and Mu50 [J].

Hanaki, H ;

Kuwahara-Arai, K ;

Boyle-Vavra, S ;

Daum, RS ;

Labischinski, H ;

Hiramatsu, K .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 42 (02) :199-209

← 1 2 3 →